Registration Open for Brain Tumor Center Walk/Run Fundraiser
CINCINNATIWith the dateand maybe the starsaligned for a "perfect 10, the UC Brain Tumor Center is unveiling its new fundraiser, Walk Ahead for a Brain Tumor Cure, on 10/10/2010.
The 5-kilometer walk/run will begin at 10 a.m. at the World Peace Bell at Fourth and York streets in Newport. Participants will cross the Purple People Bridge and finish at Yeatmans Cove on the Cincinnati riverfront. The route is wheelchair-accessible and includes two water stations. A celebration following the walk/run will feature music and refreshments.
Proceeds will benefit the research and education programs at the Brain Tumor Center at the University of Cincinnati (UC) Neuroscience Institute. Chairing the event are Wally Pagan and Christopher Knueven.
The entry fee is $30 online, $25 if paid by check, with no charge for children under 12. Participants are encouraged to form teams and recruit friends and family to support their walk/run efforts. Online registration is open at www.walkaheadforacure.com.
Event sponsors include Miller-Valentine Group, US Bank, Mayfield Clinic, Banks Corporation and Trauth Dairy, LLC. For information about sponsorships, please contact Gina Weitzel at (513) 558-6112 or gina.weitzel@uc.edu.
Some 215,000 people are stricken with brain tumors in
During the last two decades, the incidence of brain tumors has increased 22 percent overall and 55 percent in people over 65 years of age.
The Brain Tumor Center is one of seven specialty centers within the UC Neuroscience Institute and is a close affiliate of the Mayfield Clinic neurosurgical practice and several specialty departments of University of Cincinnati Physicians. The centers multidisciplinary clinical team of specialists uses multiple tumor-fighting therapies, from implantable chemotherapy wafers to shaped-beam radiation to promising vaccines. The center also makes new therapies available to patients through carefully managed clinical trials.
The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, multiple sclerosis, neuromuscular disorders, Alzheimers disease, Parkinsons disease, disorders of the senses (swallowing, voice, hearing, pain, taste and smell) and psychiatric conditions (bipolar disorder, schizophrenia and depression).
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.